These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1498512)

  • 1. The urinary acylcarnitine profile in three cases of transient hyperammonemia of the newborn.
    Sakuma T; Sugiyama N; Wada Y
    Acta Paediatr; 1992 May; 81(5):436-8. PubMed ID: 1498512
    [No Abstract]   [Full Text] [Related]  

  • 2. Alteration of urinary carnitine profile induced by benzoate administration.
    Sakuma T
    Arch Dis Child; 1991 Jul; 66(7):873-5. PubMed ID: 1863104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal handling of carnitine in children with carnitine deficiency and hyperammonemia associated with valproate therapy.
    Matsuda I; Ohtani Y; Ninomiya N
    J Pediatr; 1986 Jul; 109(1):131-4. PubMed ID: 3088240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carnitine palmitoyltransferase 2 deficiency: the time-course of blood and urinary acylcarnitine levels during initial L-carnitine supplementation.
    Hori T; Fukao T; Kobayashi H; Teramoto T; Takayanagi M; Hasegawa Y; Yasuno T; Yamaguchi S; Kondo N
    Tohoku J Exp Med; 2010 Jul; 221(3):191-5. PubMed ID: 20543534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary carnitine deficiency in hyperammonemic attacks of ornithine transcarbamylase deficiency.
    Ohtani Y; Ohyanagi K; Yamamoto S; Matsuda I
    J Pediatr; 1988 Mar; 112(3):409-14. PubMed ID: 3346778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical method for urinary glutarylcarnitine, acetylcarnitine and propionylcarnitine with a carboxylic acid analyser and a reversed-phase column.
    Kidouchi K; Sugiyama N; Morishita H; Wada Y; Nagai S; Sakakibara J
    J Chromatogr; 1987 Dec; 423():297-303. PubMed ID: 3443662
    [No Abstract]   [Full Text] [Related]  

  • 7. Urinary excretion of carnitine and its derivatives in newborns.
    Cederblad G; Finnström O; Mårtensson J
    Biochem Med; 1982 Apr; 27(2):260-5. PubMed ID: 7082329
    [No Abstract]   [Full Text] [Related]  

  • 8. Urinary excretion of acetylcarnitine during human diabetic and fasting ketosis.
    Hoppel CL; Genuth SM
    Am J Physiol; 1982 Aug; 243(2):E168-72. PubMed ID: 6810706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma and urinary levels of carnitine in different experimental models of hyperammonemia and the effect of sodium benzoate treatment.
    Michalak A; Qureshi IA
    Biochem Med Metab Biol; 1990 Apr; 43(2):163-74. PubMed ID: 2346672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal hyperammonemia associated with carnitine deficiency.
    Nagao M; Tsuchiyama A; Mori T; Agatsuma Y; Oyanagi K
    Tohoku J Exp Med; 1989 Aug; 158(4):317-23. PubMed ID: 2588261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of benzoylcarnitine in the urine of a patient of hyperammonemia.
    Sakuma T; Asai K; Ichiki T; Sugiyama N; Kidouchi K; Wada Y
    Tohoku J Exp Med; 1989 Oct; 159(2):147-51. PubMed ID: 2609332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitation of urinary carnitine esters in a patient with medium-chain acyl-coenzyme A dehydrogenase deficiency: effect of metabolic state and L-carnitine therapy.
    Schmidt-Sommerfeld E; Penn D; Kerner J; Bieber LL; Rossi TM; Lebenthal E
    J Pediatr; 1989 Oct; 115(4):577-82. PubMed ID: 2795349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of urinary acetylcarnitine in valproate-treated rats: the effect of L-carnitine supplementation.
    Murakami K; Sugimoto T; Nishida N; Woo M; Araki A; Kobayashi Y
    J Child Neurol; 1992 Oct; 7(4):404-7. PubMed ID: 1469250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-performance liquid chromatographic separation of acylcarnitines following derivatization with 4'-bromophenacyl trifluoromethanesulfonate.
    Minkler PE; Ingalls ST; Hoppel CL
    Anal Biochem; 1990 Feb; 185(1):29-35. PubMed ID: 2344045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal hyperammonemia caused by a defect of carnitine-acylcarnitine translocase.
    Ogier de Baulny H; Slama A; Touati G; Turnbull DM; Pourfarzam M; Brivet M
    J Pediatr; 1995 Nov; 127(5):723-8. PubMed ID: 7472823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carnitine metabolism in the vitamin B-12-deficient rat.
    Brass EP; Stabler SP
    Biochem J; 1988 Oct; 255(1):153-9. PubMed ID: 3196310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of short- and long-term treatment with valproate on carnitine homeostasis in humans.
    Morand R; Todesco L; Donzelli M; Fischer-Barnicol D; Mullen PJ; Krähenbühl S
    Ther Drug Monit; 2012 Aug; 34(4):406-14. PubMed ID: 22743351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carnitine-acylcarnitine translocase deficiency: metabolic consequences of an impaired mitochondrial carnitine cycle.
    Röschinger W; Muntau AC; Duran M; Dorland L; IJlst L; Wanders RJ; Roscher AA
    Clin Chim Acta; 2000 Aug; 298(1-2):55-68. PubMed ID: 10876004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of carnitine administration on glycine metabolism in patients with isovaleric acidemia: significance of acetylcarnitine determination to estimate the proper carnitine dose.
    Itoh T; Ito T; Ohba S; Sugiyama N; Mizuguchi K; Yamaguchi S; Kidouchi K
    Tohoku J Exp Med; 1996 Jun; 179(2):101-9. PubMed ID: 8875766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carnitine and acylcarnitine metabolism during exercise in humans. Dependence on skeletal muscle metabolic state.
    Hiatt WR; Regensteiner JG; Wolfel EE; Ruff L; Brass EP
    J Clin Invest; 1989 Oct; 84(4):1167-73. PubMed ID: 2794054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.